JPMorgan updated its outlook on Nasdaq OMX Group Inc. (NASDAQ:NDAQ), increasing the price target to $95 from the previous $88, while reaffirming an Overweight rating on the stock. Currently trading at ...

JPMorgan analyst Stephen Tusa Jr. adjusted the price target for Roper Industries (NASDAQ:ROP) upward to $558 from the ...

That is why analysts from J.P. Morgan decided to boost Cummins stock ... After stocks like Coca-Cola Co. (NYSE: KO) and PepsiCo Inc. (NASDAQ: PEP) traded lower on the proposed changes from ...

is presenting today at the 43rd Annual J.P. Morgan Healthcare Conference. During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.

Fintel reports that on December 20, 2024, JP Morgan downgraded their outlook for Kimco Realty (LSE:0JR1) from Overweight to Neutral. As of December 3, 2024, the average one-year price target for ...

Micron (NASDAQ:MU) investors faced a tough week they ... February quarter is attributed to weakness in the NAND market. J.P. Morgan analyst Harlan Sur, who ranks among the top 1% of Wall Street ...

Fintel reports that on January 28, 2025, JP Morgan upgraded their outlook for Ciena (LSE:0HYA) from Neutral to Overweight. As of December 23, 2024, the average one-year price target for Ciena is ...

Expand Energy (NASDAQ:EXE) +2.7% in Thursday's trading to an all-time high of $108.83 as J.P. Morgan launches coverage with an Outperform rating and $112 price target, citing large-scale exposure to ...

Fintel reports that on December 16, 2024, JP Morgan upgraded their outlook for Okta (NasdaqGS:OKTA) from Neutral to Overweight. As of December 3, 2024, the average one-year price target for Okta ...

RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan ...

SG Americas Securities LLC cut its stake in iShares J.P. Morgan USD Emerging Markets Bond ETF (NASDAQ:EMB – Free Report) by 24.7% during the 4th quarter, according to its most recent Form 13F ...

(RTTNews) - Seer, Inc. (SEER), a life sciences company, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare ... not necessarily reflect those of Nasdaq, Inc. Founded in the late ...